Published in Psychiatry Res on January 15, 2011
Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study. Schizophr Res (2013) 1.08
The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth. J Psychiatr Res (2013) 0.80
Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia. Schizophr Res (2015) 0.78
Odor naming and interpretation performance in 881 schizophrenia subjects: association with clinical parameters. BMC Psychiatry (2013) 0.76
Olfactory function in psychotic disorders: Insights from neuroimaging studies. World J Psychiatry (2015) 0.75
Marked changes in olfactory perception during early pregnancy: a prospective case-control study. Eur Arch Otorhinolaryngol (2014) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav (1984) 6.50
The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull (1984) 5.69
Dose-related effects of cigarette smoking on olfactory function. JAMA (1990) 1.94
Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry (1997) 1.71
Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys (1989) 1.63
Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. JAMA (2001) 1.54
Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology (1999) 1.50
Failure of positive but not negative emotional valence to enhance memory in schizophrenia. J Abnorm Psychol (2007) 1.43
Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry (2009) 1.19
Olfactory hedonic judgment in patients with deficit syndrome schizophrenia. Schizophr Bull (2009) 1.14
Impairment of odor hedonics in men with schizophrenia. Am J Psychiatry (2003) 1.13
Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives. Psychiatry Res (2007) 1.09
Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr Bull (2009) 1.08
Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments. Neuroimage (2005) 1.08
Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol Psychiatry (1997) 1.06
Various bilateral olfactory deficits in male patients with schizophrenia. Schizophr Bull (2005) 1.04
On knowing and judging smells: identification and hedonic judgment of odors in schizophrenia. Schizophr Res (2005) 1.02
Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification test. Neurosci Res (2009) 0.99
Olfactory impairment in monozygotic twins discordant for schizophrenia. Eur Arch Psychiatry Clin Neurosci (2004) 0.97
Ratings of different olfactory judgements in schizophrenia. Chem Senses (2002) 0.96
Increased processing speed for emotionally negative odors in schizophrenia. Int J Psychophysiol (2008) 0.81
Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol (2006) 3.02
Facial emotion perception in schizophrenia: a meta-analytic review. Schizophr Bull (2009) 2.98
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry (2005) 2.59
An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia. Am J Psychiatry (2008) 2.53
An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatry (2002) 2.50
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord (2014) 2.30
Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimers Dement (2012) 2.13
Working memory for complex figures: an fMRI comparison of letter and fractal n-back tasks. Neuropsychology (2002) 2.07
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc (2004) 2.00
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc (2008) 1.92
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Brain activation during facial emotion processing. Neuroimage (2002) 1.76
Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol (2003) 1.71
Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am J Psychiatry (2004) 1.64
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord (2011) 1.57
The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms of repeat administration. Arch Clin Neuropsychol (2004) 1.57
Age-related differences in brain activation during emotional face processing. Neurobiol Aging (2002) 1.54
Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord (2008) 1.49
Evidence for impaired encoding and retrieval memory profiles in Parkinson disease. Cogn Behav Neurol (2004) 1.34
Antidepressant studies in Parkinson's disease: a review and meta-analysis. Mov Disord (2005) 1.32
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Neuropsychological deficits among patients with late-onset minor and major depression. Arch Clin Neuropsychol (2003) 1.30
Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol (2010) 1.29
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Facial emotion perception in depression and bipolar disorder: a quantitative review. Psychiatry Res (2011) 1.27
Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol (2011) 1.26
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. Am J Psychiatry (2007) 1.24
"It's Not What You Say, But How You Say it": A Reciprocal Temporo-frontal Network for Affective Prosody. Front Hum Neurosci (2010) 1.23
The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochem Res (2004) 1.23
Brain region and sex differences in age association with brain volume: a quantitative MRI study of healthy young adults. Am J Geriatr Psychiatry (2002) 1.21
Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol (2010) 1.20
Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. J Clin Exp Neuropsychol (2006) 1.18
Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology (2002) 1.17
Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med (2005) 1.15
Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study. Schizophr Bull (2005) 1.13
Impairment of odor hedonics in men with schizophrenia. Am J Psychiatry (2003) 1.13
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biol Psychiatry (2004) 1.11
Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Arch Gen Psychiatry (2003) 1.09
Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr Bull (2009) 1.08
The modular neuroarchitecture of social judgments on faces. Cereb Cortex (2011) 1.07
Hemodynamic responses in neural circuitries for detection of visual target and novelty: An event-related fMRI study. Hum Brain Mapp (2007) 1.07
Incongruence effects in crossmodal emotional integration. Neuroimage (2010) 1.07
Global-local visual processing in schizophrenia: evidence for an early visual processing deficit. Biol Psychiatry (2005) 1.05
Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull (2013) 1.04
Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures. Neuropsychology (2002) 1.04
Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry (2003) 1.03
Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains. Brain Res (2003) 1.03
Physiologic impairment of olfactory stimulus processing in schizophrenia. Biol Psychiatry (2003) 1.03
Auditory Oddball fMRI in Schizophrenia: Association of Negative Symptoms with Regional Hypoactivation to Novel Distractors. Brain Imaging Behav (2008) 1.02
Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology (2008) 1.01
Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. Neuropsychopharmacology (2004) 1.00
Crossmodal interactions in audiovisual emotion processing. Neuroimage (2011) 0.99
Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res (2010) 0.99
Not pitch perfect: sensory contributions to affective communication impairment in schizophrenia. Biol Psychiatry (2011) 0.98
Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res (2011) 0.97
Dimensions of executive function in Parkinson's disease. Dement Geriatr Cogn Disord (2005) 0.97
Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis. World J Biol Psychiatry (2011) 0.96
Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology (2010) 0.96
Computerized neurocognitive test performance in schizophrenia: a lifespan analysis. Am J Geriatr Psychiatry (2012) 0.95
Unirhinal olfactory function in schizophrenia patients and first-degree relatives. J Neuropsychiatry Clin Neurosci (2006) 0.95
Neuropsychological performance in older patients with schizophrenia: a meta-analysis of cross-sectional and longitudinal studies. Schizophr Bull (2010) 0.94
Modulating the processing of emotional stimuli by cognitive demand. Soc Cogn Affect Neurosci (2011) 0.93
Behavioral and physiological findings of gender differences in global-local visual processing. Brain Cogn (2005) 0.93
Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg (2007) 0.93
Emotional graphic cigarette warning labels reduce the electrophysiological brain response to smoking cues. Addict Biol (2013) 0.92
Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease. Parkinsonism Relat Disord (2006) 0.90
Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease. Schizophr Res (2002) 0.89
Normative data for the symbol cancellation test in young healthy adults. Appl Neuropsychol (2004) 0.88
Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol Psychiatry (2013) 0.88
Task- and resting-state functional connectivity of brain regions related to affection and susceptible to concurrent cognitive demand. Neuroimage (2013) 0.88
Smaller nasal volumes as stigmata of aberrant neurodevelopment in schizophrenia. Am J Psychiatry (2004) 0.88
Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology (2008) 0.87
Medication management and neuropsychological performance in Parkinson's disease. Clin Neuropsychol (2011) 0.86
Reduced posterior nasal cavity volume: a gender-specific neurodevelopmental abnormality in schizophrenia. Schizophr Res (2007) 0.86
Olfactory physiological impairment in first-degree relatives of schizophrenia patients. Schizophr Res (2008) 0.85
Scent of a disorder: olfactory functioning in schizophrenia. Curr Psychiatry Rep (2003) 0.85
Striatal intrinsic reinforcement signals during recognition memory: relationship to response bias and dysregulation in schizophrenia. Front Behav Neurosci (2011) 0.84
Ventrolateral prefrontal cortex and the effects of task demand context on facial affect appraisal in schizophrenia. Soc Cogn Affect Neurosci (2010) 0.84
Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel. Assessment (2004) 0.83
Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients. Schizophr Bull (2011) 0.83
Misdiagnosis of schizophrenia in a patient with psychotic symptoms. Neuropsychiatry Neuropsychol Behav Neurol (2002) 0.83
Olfaction and schizophrenia clinical risk status: just the facts. Schizophr Res (2012) 0.83
Auditory processing under cross-modal visual load investigated with simultaneous EEG-fMRI. PLoS One (2012) 0.83
The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. Bipolar Disord (2010) 0.83
Phenylthiocarbamide perception in patients with schizophrenia and first-degree family members. Am J Psychiatry (2005) 0.82
Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance. Schizophr Res (2007) 0.82
The TCN/AACN 2010 "salary survey": professional practices, beliefs, and incomes of U.S. neuropsychologists. Clin Neuropsychol (2011) 0.82
Modulation of affective face processing deficits in Schizophrenia by congruent emotional sounds. Soc Cogn Affect Neurosci (2012) 0.81
Verbal learning and memory in older adults with minor and major depression. Arch Clin Neuropsychol (2011) 0.81
Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology (2004) 0.81
Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. Nicotine Tob Res (2010) 0.81